K-Bio’s Innovative Technologies Captivate Global Pharma South Korea’s biotechnology industry is on the verge of opening a new chapter — the era of 20 trillion won in annual technology exports for the first time in h

"South Korea is no longer a latecomer, but a global innovation partner."
#bio #pharma #bigpharma #ablbio #alteogen #biotechnology #export #it #itchosun #chosun #SouthKorea #Korea #NewsUpdate

ABL Bio, Aiming to Solidify Ties with Big Pharma This Year As ABL Bio’s pipeline of novel drug candidates continues to make steady clinical progress, the company has declared that 2025 will be a turning point toward ex

The company has declared that 2025 will be a turning point toward explosive growth and establishing a solid foundation for collaboration with global pharmaceutical giants.
#bio #ablbio #bigpharma #drug #clinical #global #pharmaceutical #it #itchosun #chosun #SouthKorea #Korea #NewsUpdate